Sorry, the page you are looking for is not available
Home
The information provided on this website has been developed by Alexion, AstraZeneca Rare Disease. It is intended for medical staff, patients, and carers to prompt the timely evaluation and treatment of NMOSD in emergency situations. It provides key information about NMOSD and actions with the aim of preventing irreversible inflammation.